{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T01:13:15Z","timestamp":1784077995665,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T00:00:00Z","timestamp":1677542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Intervent Radiol"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s00270-023-03388-z","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T19:03:06Z","timestamp":1677610986000},"page":"460-469","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Boosted-Dose Yttrium-90 Radiation Segmentectomy or Lobectomy for Hepatocellular Carcinoma Refractory to Prior Transarterial Embolization or Chemoembolization: A Single Institution Retrospective Case Series"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8556-4563","authenticated-orcid":false,"given":"Shanmukha","family":"Srinivas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C.","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Al Jammal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee J.","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena D.","family":"Rockwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeet","family":"Minocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary T.","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,28]]},"reference":[{"issue":"17","key":"3388_CR1","first-page":"517","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","unstructured":"Centers for Disease Control and Prevention (CDC). Hepatocellular carcinoma\u2014United States, 2001\u20132006. MMWR Morb Mortal Wkly Rep. 2010;59(17):517\u201320.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"3388_CR2","doi-asserted-by":"publisher","first-page":"e0227711","DOI":"10.1371\/journal.pone.0227711","volume":"15","author":"E Lanza","year":"2020","unstructured":"Lanza E, Muglia R, Bolengo I, et al. Survival analysis of 230 patients with unresectable hepatocellular carcinoma treated with bland transarterial embolization. PLoS ONE. 2020;15(1):e0227711. https:\/\/doi.org\/10.1371\/journal.pone.0227711.","journal-title":"PLoS ONE"},{"issue":"16","key":"3388_CR3","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.4254\/wjh.v7.i16.2009","volume":"7","author":"A Facciorusso","year":"2015","unstructured":"Facciorusso A, Licinio R, Muscatiello N, Di Leo A, Barone M. Transarterial chemoembolization: evidences from the literature and applications in hepatocellular carcinoma patients. World J Hepatol. 2015;7(16):2009\u201319. https:\/\/doi.org\/10.4254\/wjh.v7.i16.2009.","journal-title":"World J Hepatol"},{"key":"3388_CR4","doi-asserted-by":"publisher","first-page":"646410","DOI":"10.3389\/fonc.2021.646410","volume":"11","author":"Q Tang","year":"2021","unstructured":"Tang Q, Huang W, Liang J, Xue J. Efficacy and safety of transarterial chemoembolization in elderly patients of advanced hepatocellular carcinoma with portal vein tumor thrombus: a retrospective study. Front Oncol. 2021;11:646410. https:\/\/doi.org\/10.3389\/fonc.2021.646410.","journal-title":"Front Oncol"},{"issue":"3","key":"3388_CR5","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/cncr.24050","volume":"115","author":"A Forner","year":"2009","unstructured":"Forner A, Ayuso C, Varela M, et al. Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma: are response evaluation criteria in solid tumors reliable? Cancer. 2009;115(3):616\u201323. https:\/\/doi.org\/10.1002\/cncr.24050.","journal-title":"Cancer"},{"issue":"20","key":"3388_CR6","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.4161\/cc.8.20.9701","volume":"8","author":"JM Heddleston","year":"2009","unstructured":"Heddleston JM, Li Z, McLendon RE, Hjelmeland AB, Rich JN. The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle. 2009;8(20):3274\u201384. https:\/\/doi.org\/10.4161\/cc.8.20.9701.","journal-title":"Cell Cycle"},{"issue":"4","key":"3388_CR7","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/hep.29691","volume":"68","author":"R Salem","year":"2018","unstructured":"Salem R, Gabr A, Riaz A, et al. Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1000-patient 15-year experience. Hepatology. 2018;68(4):1429\u201340. https:\/\/doi.org\/10.1002\/hep.29691.","journal-title":"Hepatology"},{"issue":"5","key":"3388_CR8","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s12325-016-0324-7","volume":"33","author":"JR Kallini","year":"2016","unstructured":"Kallini JR, Gabr A, Salem R, Lewandowski RJ. Transarterial radioembolization with Yttrium-90 for the treatment of hepatocellular carcinoma. Adv Ther. 2016;33(5):699\u2013714. https:\/\/doi.org\/10.1007\/s12325-016-0324-7.","journal-title":"Adv Ther"},{"issue":"3","key":"3388_CR9","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1148\/radiol.2018181494","volume":"289","author":"V Chernyak","year":"2018","unstructured":"Chernyak V, Fowler KJ, Kamaya A, et al. Liver Imaging Reporting and Data System (LI-RADS) Version 2018: imaging of hepatocellular carcinoma in at-risk patients. Radiology. 2018;289(3):816\u201330. https:\/\/doi.org\/10.1148\/radiol.2018181494.","journal-title":"Radiology"},{"issue":"1","key":"3388_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1055\/s-0030-1247132","volume":"30","author":"R Lencioni","year":"2010","unstructured":"Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30(1):52\u201360. https:\/\/doi.org\/10.1055\/s-0030-1247132.","journal-title":"Semin Liver Dis"},{"issue":"8","key":"3388_CR11","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/lt.21197","volume":"13","author":"A Luca","year":"2007","unstructured":"Luca A, Angermayr B, Bertolini G, et al. An integrated MELD model including serum sodium and age improves the prediction of early mortality in patients with cirrhosis. Liver Transplant. 2007;13(8):1174\u201380. https:\/\/doi.org\/10.1002\/lt.21197.","journal-title":"Liver Transplant"},{"issue":"3","key":"3388_CR12","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/hep.21563","volume":"45","author":"PS Kamath","year":"2007","unstructured":"Kamath PS, Kim WR. Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD). Hepatology. 2007;45(3):797\u2013805. https:\/\/doi.org\/10.1002\/hep.21563.","journal-title":"Hepatology"},{"issue":"8","key":"3388_CR13","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/bjs.1800600817","volume":"60","author":"RN Pugh","year":"1973","unstructured":"Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646\u20139. https:\/\/doi.org\/10.1002\/bjs.1800600817.","journal-title":"Br J Surg"},{"issue":"6","key":"3388_CR14","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","volume":"33","author":"PJ Johnson","year":"2015","unstructured":"Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015;33(6):550\u20138. https:\/\/doi.org\/10.1200\/JCO.2014.57.9151.","journal-title":"J Clin Oncol"},{"issue":"10","key":"3388_CR15","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.jvir.2017.06.019","volume":"28","author":"O Khalilzadeh","year":"2017","unstructured":"Khalilzadeh O, Baerlocher MO, Shyn PB, et al. Proposal of a new adverse event classification by the Society of Interventional Radiology Standards of Practice Committee. J Vasc Interv Radiol. 2017;28(10):1432-1437.e3. https:\/\/doi.org\/10.1016\/j.jvir.2017.06.019.","journal-title":"J Vasc Interv Radiol"},{"key":"3388_CR16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3389\/fonc.2014.00255","volume":"4","author":"SM Srinivas","year":"2014","unstructured":"Srinivas SM, Natarajan N, Kuroiwa J, et al. Determination of radiation absorbed dose to primary liver tumors and normal liver tissue using post-radioembolization (90)Y PET. Front Oncol. 2014;4:255. https:\/\/doi.org\/10.3389\/fonc.2014.00255.","journal-title":"Front Oncol"},{"issue":"8","key":"3388_CR17","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s00259-019-04340-5","volume":"46","author":"R Salem","year":"2019","unstructured":"Salem R, Padia SA, Lam M, et al. Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group. Eur J Nucl Med Mol Imaging. 2019;46(8):1695\u2013704. https:\/\/doi.org\/10.1007\/s00259-019-04340-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"3388_CR18","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1007\/s00270-017-1739-5","volume":"40","author":"EG Klompenhouwer","year":"2017","unstructured":"Klompenhouwer EG, Dresen RC, Verslype C, et al. Safety and efficacy of transarterial radioembolisation in patients with intermediate or advanced stage hepatocellular carcinoma refractory to chemoembolisation. Cardiovasc Interv Radiol. 2017;40(12):1882\u201390. https:\/\/doi.org\/10.1007\/s00270-017-1739-5.","journal-title":"Cardiovasc Interv Radiol"},{"issue":"3","key":"3388_CR19","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1007\/s00330-020-07231-8","volume":"31","author":"A Sarwar","year":"2021","unstructured":"Sarwar A, Kudla A, Weinstein JL, et al. Yttrium-90 radioembolization using MIRD dosimetry with resin microspheres. Eur Radiol. 2021;31(3):1316\u201324. https:\/\/doi.org\/10.1007\/s00330-020-07231-8.","journal-title":"Eur Radiol"},{"issue":"2","key":"3388_CR20","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ijrobp.2013.05.041","volume":"87","author":"MG Lam","year":"2013","unstructured":"Lam MG, Abdelmaksoud MH, Chang DT, et al. Safety of 90Y radioembolization in patients who have undergone previous external beam radiation therapy. Int J Radiat Oncol Biol Phys. 2013;87(2):323\u20139. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.05.041.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"3388_CR21","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.jvir.2016.03.046","volume":"27","author":"GE Johnson","year":"2016","unstructured":"Johnson GE, Monsky WL, Valji K, Hippe DS, Padia SA. Yttrium-90 radioembolization as a salvage treatment following chemoembolization for hepatocellular carcinoma. J Vasc Interv Radiol. 2016;27(8):1123\u20139. https:\/\/doi.org\/10.1016\/j.jvir.2016.03.046.","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"3388_CR22","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1053\/j.gastro.2009.09.006","volume":"138","author":"R Salem","year":"2010","unstructured":"Salem R, Lewandowski RJ, Mulcahy MF, et al. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes. Gastroenterology. 2010;138(1):52\u201364. https:\/\/doi.org\/10.1053\/j.gastro.2009.09.006.","journal-title":"Gastroenterology"},{"issue":"5","key":"3388_CR23","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1002\/hep.26014","volume":"57","author":"V Mazzaferro","year":"2013","unstructured":"Mazzaferro V, Sposito C, Bhoori S, et al. Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2 study. Hepatology. 2013;57(5):1826\u201337. https:\/\/doi.org\/10.1002\/hep.26014.","journal-title":"Hepatology"},{"issue":"12","key":"3388_CR24","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/S1470-2045(17)30683-6","volume":"18","author":"V Vilgrain","year":"2017","unstructured":"Vilgrain V, Pereira H, Assenat E, et al. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial. Lancet Oncol. 2017;18(12):1624\u201336. https:\/\/doi.org\/10.1016\/S1470-2045(17)30683-6.","journal-title":"Lancet Oncol"},{"issue":"19","key":"3388_CR25","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1200\/JCO.2017.76.0892","volume":"36","author":"PKH Chow","year":"2018","unstructured":"Chow PKH, Gandhi M, Tan SB, et al. SIRveNIB: selective internal radiation therapy versus sorafenib in Asia-Pacific patients with hepatocellular carcinoma. J Clin Oncol. 2018;36(19):1913\u201321. https:\/\/doi.org\/10.1200\/JCO.2017.76.0892.","journal-title":"J Clin Oncol"},{"issue":"9","key":"3388_CR26","doi-asserted-by":"publisher","first-page":"e0184597","DOI":"10.1371\/journal.pone.0184597","volume":"12","author":"K Katsanos","year":"2017","unstructured":"Katsanos K, Kitrou P, Spiliopoulos S, Maroulis I, Petsas T, Karnabatidis D. Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: a network meta-analysis of randomized controlled trials. PLoS ONE. 2017;12(9):e0184597. https:\/\/doi.org\/10.1371\/journal.pone.0184597.","journal-title":"PLoS ONE"},{"issue":"4","key":"3388_CR27","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s11604-007-0216-5","volume":"26","author":"N Maeda","year":"2008","unstructured":"Maeda N, Osuga K, Mikami K, et al. Angiographic evaluation of hepatic arterial damage after transarterial chemoembolization for hepatocellular carcinoma. Radiat Med. 2008;26(4):206\u201312. https:\/\/doi.org\/10.1007\/s11604-007-0216-5.","journal-title":"Radiat Med"},{"issue":"3","key":"3388_CR28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s003300050159","volume":"7","author":"L Belli","year":"1997","unstructured":"Belli L, Magistretti G, Puricelli GP, Damiani G, Colombo E, Cornalba GP. Arteritis following intra-arterial chemotherapy for liver tumors. Eur Radiol. 1997;7(3):323\u20136. https:\/\/doi.org\/10.1007\/s003300050159.","journal-title":"Eur Radiol"},{"issue":"2","key":"3388_CR29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00270-002-2524-6","volume":"26","author":"JF Geschwind","year":"2003","unstructured":"Geschwind JF, Ramsey DE, Cleffken B, et al. Transcatheter arterial chemoembolization of liver tumors: effects of embolization protocol on injectable volume of chemotherapy and subsequent arterial patency. Cardiovasc Interv Radiol. 2003;26(2):111\u20137. https:\/\/doi.org\/10.1007\/s00270-002-2524-6.","journal-title":"Cardiovasc Interv Radiol"}],"container-title":["CardioVascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-023-03388-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00270-023-03388-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00270-023-03388-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T15:05:37Z","timestamp":1680102337000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00270-023-03388-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,28]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["3388"],"URL":"https:\/\/doi.org\/10.1007\/s00270-023-03388-z","relation":{},"ISSN":["0174-1551","1432-086X"],"issn-type":[{"value":"0174-1551","type":"print"},{"value":"1432-086X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,28]]},"assertion":[{"value":"18 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this type of study formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"This study has obtained IRB approval from UCSD IRB # 210122. The need for informed consent was waived.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"All authors have reviewed this manuscript and support its submission. The need for informed consent from those involved in the study was waived due to its retrospective nature.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}